(Q39982887)

16 September 2017

title

Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines (English)

1 reference

16 September 2017

0 references

M S Floyd

1

1 reference

16 September 2017

S J Teahan

series ordinal

2

1 reference

16 September 2017

J M Fitzpatrick

series ordinal

3

1 reference

16 September 2017

R W G Watson

series ordinal

4

1 reference

16 September 2017

publication date

13 May 2008

1 reference

Prostate Cancer and Prostatic Diseases

16 September 2017

published in

1 reference

16 September 2017

volume

12

1 reference

16 September 2017

issue

1

1 reference

16 September 2017

page(s)

25-33

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2008.23

16 September 2017

exact match

0 references

cites work

Treatment of bone complications in advanced prostate cancer: rationale for bisphosphonate use and results of a phase III trial with zoledronic acid

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

The role of antiandrogen monotherapy in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Induction of invasive phenotype by Casodex in hormone-sensitive prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

To die or not to die: an overview of apoptosis and its role in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Apoptosis without caspases: an inefficient molecular guillotine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Antiandrogen-induced cell death in LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Pharmacodynamics and pharmacokinetics of bicalutamide: defining an active dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Calpain: a protease in search of a function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Downregulation of IRS-1 protein in thapsigargin-treated human prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Casodex--mechanisms of action and opportunities for usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Effects of finasteride and bicalutamide on prostatic blood flow in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Caspase-dependent activation of calpain during drug-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

Calpain inhibitors and serine protease inhibitors can produce apoptosis in HL-60 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.23

31 March 2020

Identifiers

DOI

10.1038/PCAN.2008.23

1 reference

Dimensions Publication ID

16 September 2017

1037758396

0 references

1 reference